Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,A1BG,Alpha-1B-glycoprotein,2143,83,8.59 [2.41-30.58],0.0009049271658342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABCA2,ATP-binding cassette sub-family A member 2,2068,81,2.09 [1.44-3.05],0.0001228823690364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE,Angiotensin-converting enzyme,2148,83,3.08 [1.52-6.21],0.0017108334447892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",2437,97,1.84 [1.45-2.32],3.4199787238998024e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,2462,98,6.80 [4.50-10.27],8.998773963826963e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,2461,99,2.82 [2.10-3.78],6.166898630289434e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2078,82,2.41 [1.54-3.79],0.0001311551147226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2463,98,2.70 [1.71-4.27],2.100988047937089e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2506,101,2.89 [1.63-5.11],0.0002691133140091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,2502,102,2.63 [1.57-4.40],0.0002372525022963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2130,82,3.14 [1.87-5.28],1.5096240367526106e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,2078,82,2.95 [1.42-6.13],0.003695323640557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,2437,97,1.64 [1.15-2.36],0.0068067251208075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL2,ADAMTS-like protein 2,2147,82,2.43 [1.57-3.79],7.703841071565104e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL5,ADAMTS-like protein 5,2138,84,1.80 [1.18-2.76],0.0064045678906449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,2462,98,3.27 [2.29-4.67],8.559137005211861e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRD1,Adhesion G-protein coupled receptor D1,2109,80,2.14 [1.36-3.37],0.0010062880504232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE2,Adhesion G protein-coupled receptor E2,2496,99,2.99 [1.76-5.10],5.48326778965294e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE5,Adhesion G protein-coupled receptor E5,2497,102,3.05 [2.02-4.59],9.876826147534337e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,2475,101,1.42 [1.23-1.63],1.0238635231993524e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG2,Adhesion G-protein coupled receptor G2,2483,101,0.40 [0.22-0.73],0.0026553504569259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,2437,97,0.71 [0.57-0.87],0.0013461646887029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,2500,102,10.15 [5.25-19.60],5.342846356455976e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFM,Afamin,2143,83,0.29 [0.13-0.66],0.0032690383049513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFP,Alpha-fetoprotein,2456,98,0.59 [0.44-0.79],0.0004353525632125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,2399,92,1.41 [1.20-1.67],4.267351612522956e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,2496,99,3.64 [2.63-5.04],5.316940193606927e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRP,Agouti-related protein,2506,101,1.99 [1.43-2.78],4.880452792805167e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1L,Allograft inflammatory factor 1-like,2096,83,1.45 [1.10-1.92],0.007803993560809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALCAM,CD166 antigen,2510,102,3.53 [1.68-7.43],0.0009054573149124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,2499,102,18.47 [8.97-38.03],2.5029266337719964e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANG,Angiogenin,2476,99,2.41 [1.54-3.79],0.00013337234689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,2500,102,3.47 [2.41-5.01],2.9184323933407913e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,2492,99,3.92 [2.73-5.63],1.484779255358949e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL7,Angiopoietin-related protein 7,2500,102,1.83 [1.20-2.80],0.0049782140486976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA5,Annexin A5,2410,94,2.30 [1.58-3.35],1.4552834544324057e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,2486,99,6.08 [3.58-10.34],2.4939271571952308e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA1,Apolipoprotein A-I,2143,83,0.30 [0.15-0.61],0.0009129422174539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA2,Apolipoprotein A-II,2148,83,1.70 [1.17-2.49],0.0059265280172663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,2143,83,4.06 [2.57-6.43],2.215827811055547e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOM,Apolipoprotein M,2485,99,0.43 [0.25-0.76],0.0033767693880998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,2475,101,2.60 [1.93-3.49],2.5381333508306816e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART3,Ecto-ADP-ribosyltransferase 3,2486,99,2.12 [1.38-3.27],0.0006578813207748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,2463,98,4.28 [2.70-6.80],6.764879221341634e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,2148,83,6.23 [3.40-11.40],3.033091081070457e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,2130,82,3.91 [2.45-6.26],1.247526457865548e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,2143,83,4.04 [2.46-6.66],3.8982069842513176e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2096,83,3.00 [1.74-5.16],7.634332495072388e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",2496,99,5.87 [3.27-10.54],2.958568257043593e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,2418,95,2.73 [1.85-4.02],3.962145479270346e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAM,Basal cell adhesion molecule,2490,100,3.23 [1.66-6.30],0.0005853419947863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP10,Bone morphogenetic protein 10,2109,80,2.63 [1.55-4.48],0.0003434697742103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMPER,BMP-binding endothelial regulator protein,2109,80,2.94 [1.64-5.27],0.000292335105998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,2078,82,1.84 [1.20-2.83],0.0052232418969177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOC,Brother of CDO,2437,97,3.40 [1.68-6.86],0.0006577556219014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,2501,101,6.63 [3.46-12.71],1.2535080394036473e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,2505,102,2.11 [1.23-3.63],0.0067448043271996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,2496,99,4.83 [3.18-7.34],1.3930974926290134e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN3A2,Butyrophilin subfamily 3 member A2,2477,100,2.19 [1.46-3.28],0.0001646465418516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QA,Complement C1q subcomponent subunit A,2495,101,3.84 [2.12-6.93],8.26157598852016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2486,99,1.56 [1.16-2.10],0.0034320598749304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7,Complement component C7,2086,82,2.94 [1.77-4.88],3.128623383941763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,2475,101,5.16 [3.46-7.71],8.935621271862618e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA14,Carbonic anhydrase 14,2500,102,2.55 [1.69-3.85],8.913807870937501e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA3,Carbonic anhydrase 3,2509,102,1.66 [1.28-2.14],0.0001224388820467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA4,Carbonic anhydrase 4,2510,102,2.27 [1.23-4.20],0.0085630255819485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB1,Calbindin,2475,101,2.22 [1.59-3.11],3.125498423326141e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB2,Calretinin,2414,94,2.11 [1.29-3.45],0.0029959516746579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCA,Calcitonin,2460,97,1.39 [1.11-1.75],0.0042565653058045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCB,Calcitonin gene-related peptide 2,2140,84,1.76 [1.34-2.32],5.3698340678018415e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLIF,Cobalamin binding intrinsic factor,2483,101,1.29 [1.07-1.57],0.0087678715797224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC80,Coiled-coil domain-containing protein 80,2483,101,1.77 [1.19-2.64],0.0048623964391668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL11,Eotaxin,2506,101,2.20 [1.36-3.56],0.0012499755944253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,2476,99,2.46 [1.74-3.50],4.258870384759271e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,2510,102,2.67 [1.94-3.68],2.1758348887408198e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL16,C-C motif chemokine 16,2510,102,1.55 [1.11-2.15],0.0094593402948223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL21,C-C motif chemokine 21,2496,99,1.56 [1.23-1.99],0.0002919999231165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL23,C-C motif chemokine 23,2496,99,1.69 [1.14-2.48],0.0082849837862694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL25,C-C motif chemokine 25,2506,101,2.35 [1.61-3.41],7.908113460696612e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL3,C-C motif chemokine 3,2477,100,1.41 [1.16-1.71],0.0006401679177332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,2503,102,3.52 [2.48-5.01],2.700984892206589e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,2500,102,3.22 [2.23-4.67],5.821293089332316e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,2490,100,3.67 [2.53-5.34],9.837934055502807e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD14,Monocyte differentiation antigen CD14,2442,97,2.25 [1.55-3.25],1.7237401261235713e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,2506,101,2.43 [1.80-3.28],6.465916069789131e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164,Sialomucin core protein 24,2490,100,2.26 [1.50-3.41],8.962531293124538e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200,OX-2 membrane glycoprotein,2477,100,2.08 [1.28-3.40],0.0033841970362245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD207,C-type lectin domain family 4 member K,2434,100,2.47 [1.63-3.74],2.0409273312635897e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD244,Natural killer cell receptor 2B4,2506,101,2.97 [1.72-5.13],9.96623232276458e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,2489,101,3.71 [2.74-5.03],3.286279790396033e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD274,Programmed cell death 1 ligand 1,2463,98,2.31 [1.67-3.19],3.772195716421474e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,2481,99,6.36 [4.33-9.33],3.5103952173127794e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD28,T-cell-specific surface glycoprotein CD28,2418,95,2.03 [1.32-3.11],0.001190922564911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300A,CMRF35-like molecule 8,2109,80,3.07 [1.61-5.89],0.0007016760729341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,2505,102,4.31 [2.81-6.61],2.4221516533384862e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,2493,102,3.24 [2.33-4.51],2.379431298090672e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LF,CMRF35-like molecule 1,2500,102,1.74 [1.31-2.32],0.0001553339119103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,2490,100,2.41 [1.63-3.55],9.524959225622744e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,2475,101,4.49 [3.10-6.50],2.0299102984069863e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2475,101,3.74 [2.42-5.77],2.662208309019029e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD4,T-cell surface glycoprotein CD4,2473,99,2.13 [1.42-3.21],0.0002617904408024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40,Tumor necrosis factor receptor superfamily member 5,2484,99,1.66 [1.23-2.23],0.000921783238148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD46,Membrane cofactor protein,2467,99,3.26 [2.10-5.05],1.2543074974800397e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD48,CD48 antigen,2492,99,2.81 [1.65-4.79],0.0001463347655236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5,T-cell surface glycoprotein CD5,2499,102,2.40 [1.69-3.40],9.373037889871372e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,2388,95,3.14 [2.03-4.84],2.413712010939519e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,2375,100,5.32 [3.32-8.53],3.9325617667885055e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD7,T-cell antigen CD7,2073,82,2.36 [1.65-3.38],2.672471838862508e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD72,B-cell differentiation antigen CD72,2109,80,1.89 [1.19-2.99],0.0068144489313296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,2505,102,5.70 [3.77-8.62],1.5242843495882995e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,2506,101,2.44 [1.78-3.34],2.413185811640444e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD80,T-lymphocyte activation antigen CD80,2138,84,2.42 [1.47-3.98],0.0005365730236027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,2477,100,2.87 [1.90-4.35],6.365361017399799e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD93,Complement component C1q receptor,2404,93,2.91 [1.84-4.61],5.49681734967032e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99,CD99 antigen,2490,100,5.90 [2.87-12.15],1.424839659891796e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99L2,CD99 antigen-like protein 2,2490,100,4.12 [2.16-7.87],1.7729707491589953e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,2385,94,2.27 [1.71-3.00],1.024698173752615e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH15,Cadherin-15,2502,101,1.35 [1.11-1.64],0.0022111809184177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH17,Cadherin-17,2483,101,1.46 [1.18-1.82],0.0005253304395843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,2505,102,3.32 [2.33-4.72],3.017565409840615e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH6,Cadherin-6,2483,101,1.89 [1.27-2.82],0.0017606600213775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDNF,Cerebral dopamine neurotrophic factor,2475,101,1.72 [1.38-2.16],2.099575186972289e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,2488,99,2.66 [1.37-5.18],0.0040092079720821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDSN,Corneodesmosin,2495,101,1.69 [1.16-2.45],0.0061556109324186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,2109,80,2.45 [1.30-4.63],0.0056241001143659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP152,Centrosomal protein of 152 kDa,2063,81,1.75 [1.21-2.54],0.0030999212682505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES2,Cocaine esterase,2475,101,1.56 [1.18-2.05],0.0015374274971573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFC1,Cryptic protein,2418,95,1.50 [1.14-1.98],0.0039389273034717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFD,Complement factor D,2143,83,4.37 [2.55-7.48],7.655358351171483e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGA,Glycoprotein hormones alpha chain,2490,100,1.46 [1.14-1.87],0.0026227898040709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,2483,101,2.63 [1.89-3.65],7.498562871334767e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAD,Chondroadherin,2109,80,0.49 [0.34-0.72],0.0002175683656017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2140,84,3.14 [2.14-4.59],4.2600696309852225e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD6,MICOS complex subunit MIC25,2133,83,2.32 [1.37-3.95],0.0018751489519936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGA,Chromogranin-A,2147,82,1.38 [1.19-1.60],2.3980995275625764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,2497,101,3.10 [2.29-4.20],2.569512390386373e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,2425,98,1.61 [1.35-1.92],9.693792219967293e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,2492,99,4.20 [2.69-6.55],2.4353564906940183e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CILP,Cartilage intermediate layer protein 1,2147,82,2.01 [1.43-2.85],7.223970313262151e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,2494,101,3.70 [2.76-4.97],2.365404741561504e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,2147,82,2.07 [1.54-2.77],1.112807956322156e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC10A,C-type lectin domain family 10 member A,2463,98,2.21 [1.37-3.56],0.0011700691503705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,2490,100,3.13 [2.02-4.85],3.520246708844133e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1A,C-type lectin domain family 1 member A,2437,97,2.31 [1.50-3.57],0.000162716785228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC3B,Tetranectin,2087,81,0.24 [0.10-0.55],0.0007383492900918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4A,C-type lectin domain family 4 member A,2477,100,0.51 [0.32-0.79],0.0026224769078902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4D,C-type lectin domain family 4 member D,2477,100,1.60 [1.25-2.05],0.0002115583598759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC5A,C-type lectin domain family 5 member A,2476,101,3.08 [1.88-5.02],6.896070501591904e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC6A,C-type lectin domain family 6 member A,2418,95,1.68 [1.18-2.40],0.0037229111289831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC7A,C-type lectin domain family 7 member A,2506,101,2.28 [1.59-3.26],6.773104740414088e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,2500,102,7.60 [4.12-14.02],8.761544540853205e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN2,Calsyntenin-2,2506,101,1.60 [1.13-2.27],0.008134351425023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,2483,101,9.69 [5.41-17.37],2.3785860018338352e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A1,Collagen alpha-1(IV) chain,2483,101,1.98 [1.45-2.71],1.8877828576626008e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,2510,102,4.24 [3.07-5.84],1.4635789591903342e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,2481,99,7.14 [4.55-11.20],1.1729851105086457e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA2,Carboxypeptidase A2,2500,100,1.46 [1.17-1.81],0.0006467722764971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPM,Carboxypeptidase M,2493,102,2.31 [1.46-3.67],0.0003831960697932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPQ,Carboxypeptidase Q,2145,82,2.33 [1.36-4.00],0.0021103264076613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPVL,Probable serine carboxypeptidase CPVL,2497,102,2.55 [1.61-4.03],6.371506510250036e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM2,Inactive carboxypeptidase-like protein X2,2138,84,4.53 [2.31-8.89],1.1236622277734789e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD1,Protein disulfide isomerase CRELD1,2109,80,2.25 [1.31-3.86],0.0032676379928533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIM1,Cysteine-rich motor neuron 1 protein,2496,99,10.03 [4.95-20.31],1.5351476025897076e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIP2,Cysteine-rich protein 2,2463,98,2.36 [1.58-3.51],2.5353190777749707e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAM,Cytotoxic and regulatory T-cell molecule,2463,98,1.77 [1.26-2.48],0.0009336610765343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,2496,99,5.13 [3.00-8.78],2.299093661814625e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG4,Chondroitin sulfate proteoglycan 4,2147,82,2.78 [1.55-4.98],0.000575411345091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG5,Chondroitin sulfate proteoglycan 5,2071,82,1.68 [1.19-2.38],0.003457426356615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,2478,98,4.39 [2.89-6.68],4.508939575656818e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSTB,Cystatin-B,2448,96,2.09 [1.40-3.12],0.0003397565669787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTHRC1,Collagen triple helix repeat-containing protein 1,2147,82,2.25 [1.27-3.97],0.0052904842473407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSB,Cathepsin B,2479,102,2.05 [1.53-2.75],1.7897407084503266e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSE,Cathepsin E,2109,80,1.97 [1.35-2.87],0.0004200474536415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSF,Cathepsin F,2489,101,1.93 [1.27-2.92],0.0019576817429313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSL,Cathepsin L1,2483,101,2.61 [1.48-4.60],0.0009080846074486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSO,Cathepsin O,2506,101,2.71 [1.69-4.34],3.314106960564964e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSS,Cathepsin S,1967,81,4.81 [2.07-11.21],0.0002720807125684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,2479,99,3.32 [2.11-5.23],2.17703126226923e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,2463,98,2.55 [1.69-3.83],7.122223043446451e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXADR,Coxsackievirus and adenovirus receptor,2477,100,1.87 [1.37-2.55],9.03483012261746e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL16,C-X-C motif chemokine 16,2507,102,3.71 [1.93-7.13],8.631398433191998e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL9,C-X-C motif chemokine 9,2496,99,1.62 [1.29-2.03],3.127115639960649e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2489,101,3.45 [2.20-5.41],7.460724266754435e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,2437,97,4.46 [2.49-7.97],4.67823337901617e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDC,Aromatic-L-amino-acid decarboxylase,2483,101,0.55 [0.39-0.77],0.0005807032080059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDR1,Epithelial discoidin domain-containing receptor 1,2505,102,4.06 [2.21-7.47],6.35949591407961e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFA1_DEFA1B,Neutrophil defensin 1,2419,96,1.90 [1.49-2.42],2.38537918889891e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK3,Dickkopf-related protein 3,2510,102,3.16 [1.85-5.41],2.673070382065487e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,2460,98,3.28 [2.47-4.35],1.6842869331019195e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,2489,101,5.39 [3.49-8.32],3.124779614707723e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMD,Dystrophin,2096,83,1.85 [1.30-2.63],0.0006148505746718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,2096,83,0.50 [0.37-0.68],1.1854504090299456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP2,Dipeptidase 2,2475,101,2.10 [1.22-3.62],0.0078102758450285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,2475,101,2.31 [1.52-3.50],8.418245728587316e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPY30,Protein dpy-30 homolog,2491,102,1.59 [1.22-2.07],0.0005786354704245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRAXIN,Draxin,2463,98,1.64 [1.13-2.39],0.0099079750663613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,2467,99,4.29 [2.80-6.57],2.2550098315909104e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG2,Desmoglein-2,2490,100,2.29 [1.39-3.78],0.0011412261399303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG4,Desmoglein-4,2469,101,0.51 [0.36-0.73],0.0001765536388545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTNB,Dystrobrevin beta,2128,82,2.33 [1.59-3.42],1.4062301345851005e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,2475,101,4.02 [2.18-7.39],7.777024541747547e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBI3_IL27,Interleukin-27,2495,102,3.00 [1.77-5.06],4.137774339121625e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,2500,102,3.90 [3.02-5.04],1.7630912822822289e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDN1,Endothelin-1,2096,83,4.78 [2.58-8.83],6.346715120077718e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,2130,82,3.78 [2.25-6.35],5.369764513725204e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2483,99,3.51 [2.28-5.43],1.4371486880728632e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFHD1,EF-hand domain-containing protein D1,2136,83,2.03 [1.27-3.23],0.0030198978570187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,2488,100,5.28 [3.60-7.75],1.822964839640929e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,2462,98,4.99 [3.55-7.01],1.7713349051704418e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFL7,Epidermal growth factor-like protein 7,2418,95,1.77 [1.15-2.70],0.0086832482632373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELN,Elastin,2138,84,3.08 [1.86-5.09],1.1316500210704276e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENG,Endoglin,2510,102,4.03 [1.64-9.90],0.0023549406805739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA1,Ephrin type-A receptor 1,2491,99,2.67 [1.58-4.51],0.0002407586821534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,2393,97,4.24 [3.03-5.93],3.020817239312816e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA4,Ephrin type-A receptor 4,2109,80,2.90 [1.42-5.90],0.0034088250475919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,2510,102,4.98 [3.28-7.56],4.932102633927022e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB6,Ephrin type-B receptor 6,2460,97,2.95 [1.88-4.63],2.667281422370831e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERMAP,Erythroid membrane-associated protein,2078,82,2.33 [1.45-3.74],0.000439421856255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,2510,102,3.60 [2.31-5.63],1.7958421734477554e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXTL1,Exostosin-like 1,2068,81,1.56 [1.17-2.07],0.002140551463018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2R,Proteinase-activated receptor 1,2492,99,1.68 [1.22-2.32],0.0016249053903852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F3,Tissue factor,2486,102,2.36 [1.32-4.21],0.0036255736835962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",2481,99,1.54 [1.30-1.82],3.846401143309141e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP2,"Fatty acid-binding protein, intestinal",2483,101,1.42 [1.17-1.71],0.0003235289766072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",2138,84,2.28 [1.73-3.00],4.9760288873546405e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",2510,102,2.04 [1.60-2.61],1.0348639647924464e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP5,Fatty acid-binding protein 5,2498,101,1.51 [1.18-1.92],0.0010696054217406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM20A,Pseudokinase FAM20A,2138,84,2.75 [1.32-5.73],0.0069015009187442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,2475,101,4.75 [2.85-7.93],2.372258746160104e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,2483,101,6.23 [4.02-9.65],2.715744279651428e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3D,Protein FAM3D,2130,82,1.58 [1.24-2.01],0.0002043446969764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAS,Tumor necrosis factor receptor superfamily member 6,2502,102,1.93 [1.45-2.57],7.686466658968894e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBLN2,Fibulin-2,2147,82,2.48 [1.45-4.26],0.0009547617732348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,2490,100,1.49 [1.14-1.96],0.0038324370765991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN1,Ficolin-1,2146,83,2.26 [1.45-3.53],0.0003136123057124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRLB,Fc receptor-like B,2418,95,1.48 [1.15-1.91],0.0021284392878808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF16,Fibroblast growth factor 16,2078,82,0.49 [0.29-0.83],0.0077892992565822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,2495,102,1.73 [1.42-2.11],8.441017732629552e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,2421,99,3.99 [2.63-6.05],6.827349788813819e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP1,Fibroblast growth factor-binding protein 1,2489,101,0.33 [0.21-0.53],5.592816217519544e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP2,Fibroblast growth factor-binding protein 2,2147,82,0.42 [0.28-0.64],3.6118876618131047e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,2489,101,3.82 [2.10-6.94],1.091303890724474e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGL1,Fibrinogen-like protein 1,2148,83,1.71 [1.26-2.33],0.0005987901621387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2463,98,4.04 [2.61-6.25],3.630743804037799e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT1,Vascular endothelial growth factor receptor 1,2471,101,1.99 [1.30-3.06],0.0016068902554647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR1,Folate receptor alpha,2476,101,3.07 [1.86-5.05],1.0629208267628117e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL1,Follistatin-related protein 1,2096,83,6.93 [2.86-16.75],1.738906677797592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,2482,99,3.78 [2.57-5.56],1.5426027583710574e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,2505,102,1.86 [1.31-2.64],0.0005125924487335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,2475,101,2.39 [1.35-4.22],0.0027218827612602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2421,99,1.68 [1.15-2.47],0.0078404885422322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCG,Pro-glucagon,2418,95,1.23 [1.08-1.42],0.0026569365347377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,2050,79,1.64 [1.19-2.24],0.0022044020438596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2475,101,2.44 [1.53-3.92],0.0002022143642049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,2510,102,2.50 [2.03-3.07],2.7921190499074226e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDNF,Glial cell line-derived neurotrophic factor,2414,94,1.87 [1.24-2.82],0.0026597956699219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,2495,102,6.84 [4.39-10.67],2.021447047214652e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA3,GDNF family receptor alpha-3,2455,97,2.53 [1.43-4.48],0.0014703353753465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,2463,98,6.65 [3.83-11.54],1.7013029850563398e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHR,Growth hormone receptor,2109,80,0.36 [0.18-0.71],0.0034289002865104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC2,PDZ domain-containing protein GIPC2,2140,84,2.79 [1.63-4.78],0.0001762728838721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GM2A,Ganglioside GM2 activator,2097,81,2.67 [1.89-3.76],2.1949736447797e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLM2,Protein GOLM2,2505,102,2.06 [1.40-3.03],0.0002319281426803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPNMB,Transmembrane glycoprotein NMB,2427,98,2.88 [1.62-5.10],0.0002942627012176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,2437,97,2.22 [1.73-2.84],3.3992839501825285e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRN,Progranulin,2477,100,3.44 [1.83-6.48],0.0001281677684598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA1,Glutathione S-transferase A1,2480,101,0.76 [0.62-0.93],0.0090263449948412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,2482,100,2.99 [2.14-4.17],1.0267790928830764e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,2499,102,2.13 [1.78-2.56],3.955742888759083e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,2490,100,2.80 [1.86-4.20],6.980202177667755e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPH,Hephaestin,2138,84,5.47 [2.49-12.00],2.263694898163511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HJV,Hemojuvelin,2136,83,1.69 [1.23-2.31],0.0011171858422871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2477,100,3.57 [2.48-5.15],9.612551522426072e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2096,83,1.93 [1.35-2.75],0.0003272973760504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,2078,82,1.91 [1.20-3.03],0.0061386452998539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA2,Heat shock-related 70 kDa protein 2,2133,83,3.31 [2.22-4.93],4.211726551307218e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,2500,102,3.52 [2.53-4.90],6.598386147041975e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2461,98,4.31 [2.88-6.45],1.3443132694288356e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYAL1,Hyaluronidase-1,2460,95,3.34 [1.93-5.77],1.5238065612952966e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYOU1,Hypoxia up-regulated protein 1,2510,102,5.79 [3.03-11.04],1.0069777296948477e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM2,Intercellular adhesion molecule 2,2510,102,3.18 [1.86-5.44],2.307602834291622e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,2414,94,1.48 [1.12-1.95],0.0060742277847882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDUA,Alpha-L-iduronidase,2500,102,1.77 [1.19-2.63],0.0048425778153978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,2081,77,2.28 [1.30-4.00],0.0041116581704312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR1,Interferon gamma receptor 1,2496,99,5.86 [3.05-11.28],1.1780068418749e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL1,Interferon lambda-1,2414,94,1.68 [1.25-2.26],0.0006293715671251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,2475,101,6.33 [3.74-10.74],6.924597337391313e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP1,Insulin-like growth factor-binding protein 1,2509,102,1.34 [1.16-1.54],6.741950148213236e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,2505,102,2.11 [1.66-2.69],1.0774600257491015e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP3,Insulin-like growth factor-binding protein 3,2486,99,0.46 [0.32-0.66],1.5748209568703993e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,2463,96,2.65 [2.10-3.34],1.519322818141671e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,2471,99,2.97 [2.13-4.16],1.8829694574923567e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,2510,102,2.77 [2.03-3.79],1.5915115140329694e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,2483,101,2.12 [1.46-3.07],7.061445158382221e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF8,Immunoglobulin superfamily member 8,2483,101,2.01 [1.38-2.93],0.000294663246036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10,Interleukin-10,2421,99,1.34 [1.13-1.60],0.0010008052607423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RB,Interleukin-10 receptor subunit beta,2496,99,3.55 [2.19-5.73],2.419082250205771e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12A_IL12B,Interleukin-12,2475,101,1.40 [1.15-1.71],0.0007688209702227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12B,Interleukin-12 subunit beta,2506,101,1.65 [1.23-2.22],0.0009190651812044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15,Interleukin-15,2477,100,1.99 [1.21-3.28],0.0067790415780741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15RA,Interleukin-15 receptor subunit alpha,2421,99,2.45 [1.53-3.93],0.0001862537143143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18,Interleukin-18,2474,99,2.08 [1.44-2.99],8.959832723772356e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18BP,Interleukin-18-binding protein,2486,99,3.17 [2.03-4.93],3.53914876787644e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18R1,Interleukin-18 receptor 1,2506,101,2.69 [1.71-4.23],1.8637260277000315e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R1,Interleukin-1 receptor type 1,2488,100,6.91 [4.05-11.81],1.4616521223965604e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL1,Interleukin-1 receptor-like 1,2502,102,2.26 [1.53-3.32],3.666121098288082e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,2460,100,2.38 [1.73-3.27],8.338753651338062e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4R,Interleukin-4 receptor subunit alpha,2477,100,2.37 [1.65-3.39],2.8675326428304816e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6ST,Interleukin-6 receptor subunit beta,2483,101,4.47 [1.79-11.16],0.0013491204514221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,2109,80,2.61 [1.87-3.64],1.7024172991805783e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL4,Early placenta insulin-like peptide,2133,83,1.98 [1.51-2.61],9.910769909760216e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSR,Insulin receptor,2078,82,5.86 [1.89-18.20],0.0022068120396671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAV,Integrin alpha-V,2500,102,0.31 [0.13-0.73],0.0076738462289902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB6,Integrin beta-6,2421,99,2.46 [1.43-4.22],0.0011438267318827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGBL1,Integrin beta-like protein 1,2147,82,1.82 [1.32-2.51],0.0002378380900943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2486,99,2.49 [1.55-3.98],0.0001483662580659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,2505,102,5.60 [3.74-8.40],7.977101242703688e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JUN,Transcription factor AP-1,2421,99,1.37 [1.09-1.74],0.0083037404116201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,2475,101,2.09 [1.43-3.07],0.000152095244552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF1C,Kinesin-like protein KIF1C,2068,81,2.33 [1.44-3.76],0.0005732641731049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK10,Kallikrein-10,2481,101,1.72 [1.16-2.56],0.0071208369938786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,2463,101,3.52 [2.24-5.54],4.8345719090192056e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK14,Kallikrein-14,2500,102,1.77 [1.22-2.57],0.0028269231428189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,2500,102,2.17 [1.81-2.61],7.80895694197881e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK6,Kallikrein-6,2485,101,2.64 [1.64-4.24],6.130571552967834e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,2506,101,2.98 [2.09-4.24],1.336185355226603e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRD1,Natural killer cells antigen CD94,2506,101,1.80 [1.25-2.58],0.0015472729019135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",2473,100,1.58 [1.28-1.95],1.7540669314024663e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYNU,Kynureninase,2506,101,0.58 [0.40-0.83],0.00297691700245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,2475,101,2.72 [1.95-3.81],4.576566521496305e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2481,99,2.58 [2.04-3.26],1.534579502557182e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,2460,97,3.81 [2.79-5.21],4.895689928137638e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN15,Lipocalin-15,2136,83,1.57 [1.29-1.91],9.42893865214974e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,2397,95,2.42 [1.82-3.22],1.432528714757969e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS1,Galectin-1,2483,101,2.35 [1.49-3.68],0.0002097050664238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3,Galectin-3,2479,100,2.61 [1.50-4.53],0.000663013691486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,2481,99,2.37 [1.82-3.09],1.4530653698354314e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS7_LGALS7B,Galectin-7,2471,101,1.72 [1.20-2.47],0.0029905658572873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,2484,99,4.46 [2.74-7.23],1.507353707680447e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,2477,100,5.60 [3.44-9.13],4.2890022163702004e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2421,99,2.23 [1.59-3.14],3.684178627177938e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB2,Lamin-B2,2140,84,3.23 [1.82-5.73],5.876524841938849e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,2136,83,4.00 [2.56-6.23],9.931995548359726e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPO,Lactoperoxidase,2397,96,1.43 [1.10-1.85],0.0068690819544078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2494,102,2.84 [1.97-4.12],2.9489244301168952e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP11,Low-density lipoprotein receptor-related protein 11,2483,101,2.39 [1.59-3.60],2.91703866558256e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,2510,102,3.58 [2.37-5.41],1.258417492266526e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,2418,95,1.45 [1.17-1.79],0.0005904868754934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,2468,99,4.20 [2.83-6.22],8.630890726173369e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,2473,98,2.34 [1.71-3.18],7.442325196399102e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY9,T-lymphocyte surface antigen Ly-9,2452,98,2.16 [1.28-3.64],0.0039597680723946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC2,MAM domain-containing protein 2,2138,84,3.21 [2.03-5.08],5.703676922400622e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,2489,101,4.75 [2.80-8.08],8.258422043956367e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN2,Matrilin-2,2488,99,2.42 [1.35-4.32],0.0028950281912485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MB,Myoglobin,2510,102,1.84 [1.45-2.34],4.275041785605177e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCAM,Cell surface glycoprotein MUC18,2486,99,1.83 [1.20-2.78],0.0050464447047906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,2481,100,1.78 [1.42-2.21],3.2654064043465226e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MENT,Protein MENT,2109,80,0.34 [0.15-0.77],0.0095877205211422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MERTK,Tyrosine-protein kinase Mer,2506,101,2.36 [1.27-4.37],0.0066191273000837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP4,Microfibril-associated glycoprotein 4,2109,80,2.97 [1.62-5.44],0.0004091905929307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP5,Microfibrillar-associated protein 5,2510,102,2.15 [1.45-3.20],0.0001561105234439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MILR1,Allergin-1,2421,99,1.58 [1.15-2.18],0.0046208053462747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLN,Promotilin,2477,100,1.32 [1.07-1.63],0.009903451543278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP10,Stromelysin-2,2480,99,1.83 [1.39-2.43],2.1768359715164392e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP12,Macrophage metalloelastase,2485,102,1.58 [1.18-2.12],0.0021278586036969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP3,Stromelysin-1,2490,100,1.50 [1.10-2.05],0.0097208196640792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP7,Matrilysin,2433,97,2.20 [1.52-3.17],2.6739120941582665e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOG,Myelin-oligodendrocyte glycoprotein,2500,102,2.47 [1.59-3.83],5.284312962857356e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLN,Mesothelin,2466,100,1.44 [1.11-1.88],0.0066616291200845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSMB,Beta-microseminoprotein,2480,102,1.37 [1.08-1.73],0.0097145320277458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSR1,Macrophage scavenger receptor types I and II,2505,102,1.70 [1.18-2.44],0.0045870549416494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,2414,94,2.02 [1.60-2.55],2.649973946033518e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC1,"Myosin-binding protein C, slow-type",2138,84,1.40 [1.09-1.79],0.0080600308071615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC2,"Myosin-binding protein C, fast-type",2096,83,1.36 [1.13-1.63],0.0009522214027596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2095,81,1.83 [1.46-2.30],2.127988410239116e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM2,Myomesin-2,2068,81,1.65 [1.16-2.34],0.0052914743337715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,2489,101,5.22 [3.16-8.61],1.0049306349163136e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,2474,100,3.21 [2.23-4.63],4.3526021740223975e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2130,82,4.35 [2.68-7.05],2.5718406935194277e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,2500,102,6.08 [3.58-10.32],2.4890042091152488e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,2483,101,3.64 [2.43-5.45],3.5072393099707435e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,2489,101,2.83 [2.11-3.79],3.422588484284227e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,2408,94,3.12 [2.44-4.01],2.630610413993516e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,2489,101,0.33 [0.24-0.47],7.47793083750749e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,2506,101,3.84 [2.36-6.26],6.217723137269192e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS1,"Nitric oxide synthase, brain",2414,94,1.86 [1.44-2.40],2.212215277769604e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH1,Neurogenic locus notch homolog protein 1,2510,102,10.74 [4.18-27.63],8.399335984479011e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH2,Neurogenic locus notch homolog protein 2,2147,82,3.50 [1.64-7.48],0.0011966586818666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH3,Neurogenic locus notch homolog protein 3,2510,102,2.09 [1.31-3.36],0.0021409869588239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,2112,82,5.40 [3.31-8.80],1.3982775566296088e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,2483,101,3.21 [2.31-4.46],3.983518867917253e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPB,Natriuretic peptides B,2437,97,1.23 [1.09-1.38],0.0005982628557096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,2500,102,1.83 [1.39-2.42],1.975631864517716e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRCAM,Neuronal cell adhesion molecule,2483,101,2.34 [1.45-3.77],0.0005002420113465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP1,Neuropilin-1,2486,99,3.61 [2.04-6.38],1.0182838553234171e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,2140,84,2.56 [1.69-3.86],7.705731983003775e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,2483,101,1.35 [1.19-1.51],1.010165656846337e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUCB2,Nucleobindin-2,2498,102,2.56 [1.65-3.96],2.6789249078470787e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUP50,Nuclear pore complex protein Nup50,2068,81,2.21 [1.40-3.49],0.0006429019759444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OCLN,Occludin,2136,83,2.38 [1.59-3.57],2.8379059890386183e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,2490,100,3.04 [2.26-4.08],1.6263275963877172e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLFM4,Olfactomedin-4,2033,78,1.26 [1.06-1.50],0.0080935091548742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPTC,Opticin,2475,101,1.66 [1.22-2.25],0.0012509687460109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,2488,99,2.56 [1.54-4.26],0.0002775384033361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM,Paralemmin-1,2120,81,2.91 [1.76-4.82],3.0654405603506987e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,2140,84,3.08 [1.99-4.77],4.565427241740052e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2130,82,2.19 [1.22-3.93],0.0085522226232712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH1,Protocadherin-1,2494,101,2.63 [1.44-4.80],0.0016164721044062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH17,Protocadherin-17,2483,101,1.71 [1.17-2.51],0.0053386138476941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH7,Protocadherin-7,2130,82,2.74 [1.90-3.93],5.182037009175732e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDHB15,Protocadherin beta-15,2133,83,1.82 [1.22-2.70],0.0030593788286208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,2510,102,1.87 [1.21-2.88],0.0044975256647252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1,Programmed cell death protein 1,2497,101,1.97 [1.45-2.69],1.6607528945828193e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,2475,101,3.83 [2.61-5.61],6.309113596669788e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRA,Platelet-derived growth factor receptor alpha,2483,101,3.37 [2.10-5.43],5.29956680248281e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEAR1,Platelet endothelial aggregation receptor 1,2510,102,3.98 [1.91-8.33],0.0002378471668427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PENK,Proenkephalin-A,2109,80,2.28 [1.33-3.92],0.0028160419546885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,2506,101,5.74 [3.68-8.96],1.4754305559189876e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP1,Peptidoglycan recognition protein 1,2497,102,2.14 [1.54-2.98],6.488853887278492e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGR,Progesterone receptor,2078,82,1.26 [1.09-1.46],0.0020298499811101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB1,Pleckstrin homology-like domain family B member 1,2130,82,2.25 [1.54-3.31],3.3132019017622506e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2463,98,3.18 [1.89-5.35],1.2436514726256912e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI16,Peptidase inhibitor 16,2148,83,3.05 [1.31-7.09],0.0094421423015247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,2447,100,1.74 [1.43-2.12],4.97677189624818e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,2458,99,3.05 [2.01-4.62],1.3887522763839098e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2490,100,5.12 [3.55-7.38],1.9587721788426817e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,2490,100,2.68 [1.78-4.03],2.5992656368876225e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,2483,101,1.86 [1.34-2.58],0.00022799305809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD1,Polycystin-1,2138,84,3.40 [1.68-6.90],0.0006974566673888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G10,Group 10 secretory phospholipase A2,2463,98,1.67 [1.23-2.25],0.0008668063765855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G7,Platelet-activating factor acetylhydrolase,2490,100,0.36 [0.23-0.56],7.508605868476162e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,2468,99,5.13 [3.10-8.50],2.2265602574899644e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLB1,"Phospholipase B1, membrane-associated",2140,84,0.55 [0.39-0.78],0.0008456089744848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,2496,101,4.05 [2.55-6.43],2.965554243994787e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL2,Podocalyxin-like protein 2,2489,101,2.28 [1.30-4.02],0.004264014236524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POF1B,Protein POF1B,2078,82,1.78 [1.21-2.63],0.0035383495007585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2475,101,1.79 [1.24-2.57],0.0016973590496334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,2114,81,1.38 [1.08-1.75],0.0091393991751689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2136,83,1.82 [1.25-2.65],0.0016502860189464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,2147,82,6.49 [3.67-11.48],1.3079632425565216e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRCP,Lysosomal Pro-X carboxypeptidase,2498,102,1.90 [1.22-2.95],0.0046648082631302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PREB,Prolactin regulatory element-binding protein,2421,99,1.93 [1.26-2.97],0.0027321234452741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,2481,99,4.75 [2.81-8.06],6.790749622715221e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG2,Bone marrow proteoglycan,2147,82,1.91 [1.35-2.71],0.0002835108824332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRL,Prolactin,2505,102,1.36 [1.12-1.66],0.0023616442638752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRRT3,Proline-rich transmembrane protein 3,2096,83,2.17 [1.42-3.32],0.0003670716494211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS22,Brain-specific serine protease 4,2078,82,1.70 [1.18-2.47],0.0046219971691722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS27,Serine protease 27,2476,101,1.89 [1.24-2.87],0.0030213921119869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,2478,99,2.86 [1.93-4.24],1.6691595720435166e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTG,Protogenin,2500,102,3.25 [1.75-6.03],0.0001981745801474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,2128,82,5.53 [2.93-10.43],1.2556210282369e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,2463,98,1.44 [1.21-1.71],3.70653721859472e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,2457,99,3.19 [2.32-4.39],7.487008127487494e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2477,100,1.69 [1.26-2.27],0.0005197989059303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTK7,Inactive tyrosine-protein kinase 7,2414,94,2.48 [1.61-3.82],3.4517199579352206e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,2510,102,2.19 [1.25-3.83],0.0061656421639588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,2130,82,1.69 [1.14-2.49],0.0085043749564565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2457,97,3.05 [2.02-4.63],1.381420167832164e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,2510,102,2.25 [1.22-4.14],0.0091544801301513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTX3,Pentraxin-related protein PTX3,2477,100,1.96 [1.25-3.08],0.0031852584262548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVR,Poliovirus receptor,2505,102,1.94 [1.30-2.89],0.0010961858929139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYY,Peptide YY,2068,81,1.38 [1.18-1.62],7.894691296057557e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QPCT,Glutaminyl-peptide cyclotransferase,2484,102,5.49 [3.05-9.88],1.36202785235834e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES2,Retinoic acid receptor responder protein 2,2486,99,1.85 [1.35-2.53],0.0001204336127165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,2136,83,2.24 [1.70-2.94],7.222023011167627e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,2475,101,1.63 [1.35-1.96],2.688439049496691e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,2463,99,2.36 [1.85-3.01],3.431662817752349e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,2510,102,1.77 [1.39-2.25],2.9368954441234222e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3A,Regenerating islet-derived protein 3-alpha,2510,102,1.61 [1.28-2.01],3.251161423970329e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,2488,99,2.84 [2.20-3.66],8.770312406300712e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,2490,100,4.04 [2.62-6.24],2.781631997024436e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,2483,101,1.89 [1.63-2.19],3.7467063169499163e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RETN,Resistin,2479,101,1.98 [1.45-2.69],1.581543113926424e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMA,Repulsive guidance molecule A,2505,102,2.01 [1.22-3.32],0.0065127718771122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMB,RGM domain family member B,2505,102,3.56 [2.19-5.79],2.8103511836630105e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,2148,83,4.89 [2.75-8.70],6.745504377034923e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,2069,79,4.56 [2.76-7.53],2.97405906721629e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,2502,102,3.56 [2.65-4.80],5.773733719973436e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,2096,83,4.88 [2.88-8.27],3.6812159697948636e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2483,101,2.30 [1.41-3.77],0.000900140556718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO1,R-spondin-1,2463,98,2.32 [1.41-3.82],0.0009856742804453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,2500,102,3.67 [2.37-5.69],5.214388412858444e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTBDN,Retbindin,2475,101,3.18 [1.87-5.42],2.1447741600010063e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,2500,102,3.99 [2.60-6.13],2.5021598923622616e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,2505,102,5.74 [3.83-8.60],2.3435142472356722e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB1,Scavenger receptor class B member 1,2414,94,1.38 [1.10-1.74],0.0058537139902409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,2409,96,3.92 [2.86-5.39],2.653715048556311e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF1,Scavenger receptor class F member 1,2510,102,2.11 [1.43-3.10],0.0001632225375306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,2505,102,4.85 [3.40-6.92],2.9888693269950645e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,2492,102,4.69 [3.15-6.99],2.909070741910921e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG3,Secretogranin-3,2488,99,2.29 [1.38-3.79],0.0012552713636664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB1A1,Uteroglobin,2488,99,2.06 [1.47-2.89],2.7030946007254524e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,2421,99,2.42 [1.77-3.32],3.8091538446921575e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN4B,Sodium channel subunit beta-4,2096,83,1.88 [1.26-2.82],0.0022187712578791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRG1,Scrapie-responsive protein 1,2138,84,2.44 [1.32-4.52],0.0044932366931259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC4,Syndecan-4,2483,101,0.51 [0.36-0.73],0.0001931546373312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEL1L,Protein sel-1 homolog 1,2096,83,2.51 [1.61-3.90],4.314267054203604e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3F,Semaphorin-3F,2483,101,2.67 [1.47-4.86],0.0012914158585467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA7A,Semaphorin-7A,2502,102,2.38 [1.53-3.71],0.0001159742990026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN8,Septin-8,2137,84,3.42 [2.11-5.55],5.864358174181848e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF1,Pigment epithelium-derived factor,2110,83,3.25 [1.59-6.64],0.0012322664955815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L,Seizure 6-like protein,2489,101,2.66 [1.55-4.57],0.0004086548174641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L2,Seizure 6-like protein 2,2475,101,2.71 [1.33-5.51],0.0058813776325019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,2459,98,1.91 [1.43-2.56],1.1717133867662e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,2147,82,4.51 [2.89-7.06],3.7480736902424704e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC1,Sialoadhesin,2496,99,2.57 [1.76-3.75],9.71419476322679e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,2477,100,2.31 [1.57-3.42],2.391331353880101e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,2500,102,2.41 [1.50-3.87],0.0002646404731708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPB1,Signal-regulatory protein beta-1,2476,99,2.12 [1.52-2.94],8.251332932948176e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF1,Signaling lymphocytic activation molecule,2421,99,1.68 [1.25-2.25],0.0005208210877239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF8,SLAM family member 8,2418,95,1.71 [1.23-2.37],0.0014560525384512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A5,Zinc transporter ZIP5,2477,100,1.69 [1.21-2.37],0.0021099384985913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK2,SLIT and NTRK-like protein 2,2500,102,2.41 [1.57-3.69],5.376303250135061e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK6,SLIT and NTRK-like protein 6,2437,97,1.88 [1.20-2.95],0.0057577622737041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,2129,82,1.97 [1.27-3.05],0.0023090276771511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,2500,102,2.51 [1.63-3.88],3.135300466506086e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,2496,99,3.07 [2.23-4.22],5.8453344038836455e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,2463,98,2.09 [1.62-2.69],1.1044675029343588e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORBS1,Sorbin and SH3 domain-containing protein 1,2136,83,1.58 [1.16-2.16],0.0038052932915133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,2418,95,2.87 [1.98-4.16],2.6954474490221053e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,2136,83,2.00 [1.21-3.32],0.0072971460018499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPESP1,Sperm equatorial segment protein 1,2138,84,2.23 [1.34-3.71],0.0020504322393726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,2490,100,2.78 [2.16-3.58],1.849312349093146e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,2477,100,2.33 [1.92-2.84],1.852400252853853e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK5,Serine protease inhibitor Kazal-type 5,2490,100,2.05 [1.28-3.27],0.0027817857131205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT2,Kunitz-type protease inhibitor 2,2496,99,2.16 [1.45-3.21],0.000140885137056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON1,Spondin-1,2488,99,2.90 [1.98-4.25],4.795486076272823e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,2475,100,3.74 [2.47-5.67],4.695857080410242e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPP1,Osteopontin,2505,102,1.58 [1.12-2.23],0.0093686739468215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR3,Small proline-rich protein 3,2140,84,1.47 [1.13-1.91],0.0042960649909038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPX,Sushi repeat-containing protein SRPX,2138,84,3.60 [2.14-6.04],1.3414081239119996e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,2483,101,0.82 [0.72-0.95],0.0058832213559174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2475,101,1.82 [1.36-2.44],6.066172366495765e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",2510,102,2.22 [1.29-3.85],0.0042014859360491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,2505,102,1.99 [1.45-2.73],2.027392991784096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC2,Stanniocalcin-2,2484,98,2.68 [1.30-5.52],0.0075422018620593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACSTD2,Tumor-associated calcium signal transducer 2,2194,90,2.72 [1.56-4.76],0.0004397681434932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,2475,101,3.33 [2.39-4.64],1.3339492170974245e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,2505,102,3.23 [2.12-4.92],4.7306557782732184e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,2479,100,1.69 [1.43-2.00],5.563030460188415e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,2492,99,1.98 [1.60-2.45],4.768154424731095e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,2462,98,2.24 [1.84-2.73],8.347723508614945e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFA,Protransforming growth factor alpha,2477,100,2.07 [1.51-2.83],5.294266721803689e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB1,Transforming growth factor beta-1 proprotein,2501,101,1.83 [1.27-2.65],0.0012828971376018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,2465,99,0.37 [0.20-0.69],0.0018047500683597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,2489,101,3.11 [2.31-4.19],7.472494159333477e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR3,Transforming growth factor beta receptor type 3,2510,102,2.75 [1.75-4.33],1.1674882412273766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGOLN2,Trans-Golgi network integral membrane protein 2,2148,83,4.27 [2.24-8.13],1.0058137151598071e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBD,Thrombomodulin,2483,101,2.41 [1.57-3.72],6.488617482052091e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS2,Thrombospondin-2,2490,100,1.54 [1.12-2.11],0.0083010062936519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THOP1,Thimet oligopeptidase,2477,101,0.51 [0.32-0.81],0.0039169825278835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,2505,102,4.15 [2.56-6.72],7.095988403046714e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP1,Metalloproteinase inhibitor 1,2444,98,2.75 [1.71-4.42],2.9687187583915315e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TINAGL1,Tubulointerstitial nephritis antigen-like,2480,101,2.75 [1.32-5.71],0.0069168374163096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM25,Transmembrane protein 25,2136,83,1.79 [1.24-2.59],0.001844720995246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS15,Enteropeptidase,2475,101,1.39 [1.15-1.68],0.0007170319992736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNF,Tumor necrosis factor,2435,96,1.61 [1.13-2.29],0.0087248055532442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2463,98,2.54 [1.94-3.34],1.9220906343533697e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2463,98,1.73 [1.51-1.97],5.802451848648285e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2506,101,3.11 [2.28-4.24],7.799895495729134e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2481,99,2.83 [1.72-4.66],4.531176567416721e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2489,101,4.25 [3.00-6.02],4.2287866529557965e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2488,99,2.02 [1.41-2.89],0.0001241535624772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2488,99,3.87 [2.78-5.38],8.612866718796688e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2500,102,3.35 [2.43-4.62],1.3895383617908068e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2490,100,4.63 [3.15-6.79],5.0032263806266046e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2490,100,2.00 [1.63-2.45],3.9824614707050334e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2505,102,3.98 [2.37-6.69],1.907211047187461e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2501,101,3.64 [2.64-5.02],3.836412800164639e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2463,98,1.56 [1.20-2.04],0.0010962953781603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2505,102,1.95 [1.39-2.74],0.0001009014132525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2463,98,2.24 [1.76-2.86],8.475409369202396e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,2496,99,7.05 [4.08-12.18],2.665758048741583e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,2507,102,2.08 [1.23-3.49],0.0060160180235654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,2147,82,2.15 [1.32-3.51],0.0022226278448245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNR,Tenascin-R,2463,98,1.80 [1.21-2.68],0.0035335121482009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSAB1,Tryptase alpha/beta-1,2504,101,1.63 [1.14-2.34],0.0080397877159246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC5,Thioredoxin domain-containing protein 5,2505,102,1.45 [1.12-1.87],0.0049651918540982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,2483,101,2.43 [1.33-4.45],0.003911574860683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,2463,98,3.53 [2.42-5.14],5.299419857585641e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,2500,102,0.44 [0.33-0.57],2.1584975426146966e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASN,Vasorin,2440,97,2.89 [1.72-4.84],5.8003143408896046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAM1,Vascular cell adhesion protein 1,2485,99,3.57 [2.17-5.88],5.921700830175052e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFB,Vascular endothelial growth factor B,2078,82,2.84 [1.43-5.65],0.0028893933050566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,2503,101,2.56 [1.72-3.81],3.838005977187137e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VMO1,Vitelline membrane outer layer protein 1 homolog,2475,101,1.71 [1.28-2.27],0.0002544789486182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,2133,83,1.84 [1.47-2.29],6.19824756243548e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,2484,98,2.83 [2.04-3.93],5.207141440437653e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM1,V-set and transmembrane domain-containing protein 1,2414,94,1.60 [1.15-2.25],0.0058821716332423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,2459,97,3.10 [2.10-4.58],1.3017697412193998e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,2358,93,3.11 [2.33-4.16],1.4702407797028145e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,2421,99,2.33 [1.71-3.18],9.390214038118058e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XCL1,Lymphotactin,2500,102,1.46 [1.10-1.95],0.0095623120655274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,2497,101,3.85 [2.73-5.44],1.918695939902932e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,2140,84,5.55 [3.24-9.49],4.3136120824927183e-10
